Jeff Kraws Weighs In on Supreme Court Victory for Generic Drug Makers

Posted by Colleen Koski

April 19, 2012 at 3:03 AM

Novo Nordisk PrandinYesterday, Crystal Research CEO Jeffrey Kraws and NPR's correspondent Yuki Noguchi discussed the impact of a U.S. Supreme Court decision that allows generic drug makers to challenge brand-name rivals suspected of overstating the reach of their patents in regulatory filings. The full audio clip and transcript are available here.

Read More

Topics: Crystal Research Associates, Novo Nordisk, generic drugs

Content not found
Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

see all

Posts by Topic